BioCentury’s roundup of translational innovations

Presentations highlight gene edits and CAR engineering to improve efficacy of NK cell therapies

How new NK cell targets could lead to more powerful checkpoint inhibitors

New targets at AACR suggest non-coding RNAs are on the rise

CanCure, Novelogics join Innate in a race for mAbs against soluble MICs

Galileo stem cell therapy a broader cancer killer than antigen-specific vaccines